Preclinical, Publications CAM-E and CAM-A Compounds Differentially Affect Phosphorylated and Non-Phosphorylated Hepatitis B Core Protein In Vitro
Preclinical, Publications Differentiation of HBV capsid assembly modulators based on stabilization of core protein oligomerization and residence time
Preclinical, Publications Antisense oligonucleotide-based strategy to target hepatitis delta virus infections
Preclinical, Publications Differential impact of CAM-E and CAM-A on hepatitis B core protein phosphorylation states in vitro
Preclinical, Publications PML nuclear bodies store aggregated HBc and reduce CAM-induced apoptosis in HBc-expressing cells
Preclinical, Publications Antisense oligonucleotides as drugs with both direct and indirect antiviral actions
Preclinical, Publications Discovery and Preclinical Characterization of ALG-093940, a Potent and Orally Bioavailable Small Molecule PD-L1 Inhibitor for the Treatment of Cancer
Preclinical, Publications Two Pre-clinical Short Interfering RNA (siRNA) Molecules Targeting Human HSD17β13 for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis
Preclinical, Publications Discovery and Optimization of the Pre-Clinical Efficacy of Human PNPLA3-Targeting Short Interfering RNA Molecules (siRNAs) for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis